Special rating instructions

• Loss of temporal half of visual field:
• Or evaluate each affected eye as 20/70 (6/21)
• Loss of nasal half of visual field:
• Or evaluate each affected eye as 20/50 (6/15)
• Loss of inferior half of visual field:
• Or evaluate each affected eye as 20/70 (6/21)
• Loss of superior half of visual field:
• Or evaluate each affected eye as 20/50 (6/15)
• Concentric contraction of visual field:
• With remaining field of 5 degrees: 1
• Or evaluate each affected eye as 5/200 (1.5/60)
• With remaining field of 6 to 15 degrees:
• Or evaluate each affected eye as 20/200 (6/60)
• With remaining field of 16 to 30 degrees:
• Or evaluate each affected eye as 20/100 (6/30)
• With remaining field of 31 to 45 degrees:
• Or evaluate each affected eye as 20/70 (6/21)
• With remaining field of 46 to 60 degrees:
• Or evaluate each affected eye as 20/50 (6/15)
• Loss of temporal half of visual field: Or evaluate each affected eye as 20/70 (6/21) Loss of nasal half of visual field: Or evaluate each affected eye as 20/50 (6/15) Loss of inferior half of visual field: Or evaluate each affected eye as 20/70 (6/21) Loss of superior half of visual field: Or evaluate each affected eye as 20/50 (6/15) Concentric contraction of visual field: With remaining field of 5 degrees: 1 Or evaluate each affected eye as 5/200 (1.5/60) With remaining field of 6 to 15 degrees: Or evaluate each affected eye as 20/200 (6/60) With remaining field of 16 to 30 degrees: Or evaluate each affected eye as 20/100 (6/30) With remaining field of 31 to 45 degrees: Or evaluate each affected eye as 20/70 (6/21) With remaining field of 46 to 60 degrees: Or evaluate each affected eye as 20/50 (6/15)
• Loss of temporal half of visual field: Or evaluate each affected eye as 20/70 (6/21) Loss of nasal half of visual field: Or evaluate each affected eye as 20/50 (6/15) Loss of inferior half of visual field: Or evaluate each affected eye as 20/70 (6/21) Loss of superior half of visual field: Or evaluate each affected eye as 20/50 (6/15) Concentric contraction of visual field: With remaining field of 5 degrees: 1 Or evaluate each affected eye as 5/200 (1.5/60) With remaining field of 6 to 15 degrees: Or evaluate each affected eye as 20/200 (6/60) With remaining field of 16 to 30 degrees: Or evaluate each affected eye as 20/100 (6/30) With remaining field of 31 to 45 degrees: Or evaluate each affected eye as 20/70 (6/21) With remaining field of 46 to 60 degrees: Or evaluate each affected eye as 20/50 (6/15)
• Loss of temporal half of visual field: Or evaluate each affected eye as 20/70 (6/21) Loss of nasal half of visual field: Or evaluate each affected eye as 20/50 (6/15) Loss of inferior half of visual field: Or evaluate each affected eye as 20/70 (6/21) Loss of superior half of visual field: Or evaluate each affected eye as 20/50 (6/15) Concentric contraction of visual field: With remaining field of 5 degrees: 1 Or evaluate each affected eye as 5/200 (1.5/60) With remaining field of 6 to 15 degrees: Or evaluate each affected eye as 20/200 (6/60) With remaining field of 16 to 30 degrees: Or evaluate each affected eye as 20/100 (6/30) With remaining field of 31 to 45 degrees: Or evaluate each affected eye as 20/70 (6/21) With remaining field of 46 to 60 degrees: Or evaluate each affected eye as 20/50 (6/15)
• Loss of temporal half of visual field: Or evaluate each affected eye as 20/70 (6/21) Loss of nasal half of visual field: Or evaluate each affected eye as 20/50 (6/15) Loss of inferior half of visual field: Or evaluate each affected eye as 20/70 (6/21) Loss of superior half of visual field: Or evaluate each affected eye as 20/50 (6/15) Concentric contraction of visual field: With remaining field of 5 degrees: 1 Or evaluate each affected eye as 5/200 (1.5/60) With remaining field of 6 to 15 degrees: Or evaluate each affected eye as 20/200 (6/60) With remaining field of 16 to 30 degrees: Or evaluate each affected eye as 20/100 (6/30) With remaining field of 31 to 45 degrees: Or evaluate each affected eye as 20/70 (6/21) With remaining field of 46 to 60 degrees: Or evaluate each affected eye as 20/50 (6/15)
• General Rating Formula for Diseases of the Eye:
• Evaluate on the basis of either visual impairment due to the particular condition or on incapacitating episodes, whichever results in a higher evaluation
• Note (1): For the purposes of evaluation under 38 CFR 4.79, an incapacitating episode is an eye condition severe enough to require a clinic visit to a provider specifically for treatment purposes
• Note (2): Examples of treatment may include but are not limited to: Systemic immunosuppressants or biologic agents; intravitreal or periocular injections; laser treatments; or other surgical interventions
• Note (3): For the purposes of evaluating visual impairment due to the particular condition, refer to 38 CFR 4.75-4.78 and to § 4.79, diagnostic codes 6061-6091

Body system and anatomy metadata

Body system: Eye

Anatomy / region tags: head, sensory system

These tags support discovery and body-map compatibility. They do not establish Veteran-specific laterality or entitlement.

Official VA DBQ references

DBQ catalog: va-dbq-2026.09.16 · Retrieved 2026-09-16. Official VA inventory ↗

• Eye Conditions ↗ Related resourceCatalog category: Ophthalmological

  Related by body system only. No reviewed condition-specific form match or requirement has been established.

VA maintains some examination forms that are not available for public use. VMC does not infer a one-code-to-one-DBQ relationship.

Evidence information

When reviewing the criteria, useful evidence categories can include diagnosis and treatment records, objective testing identified by the schedule, documented frequency/duration/severity when the criteria use those concepts, and functional effects described in medical or lay evidence. The relevant evidence depends on the actual claim and medical facts.

VMC does not diagnose conditions, guarantee a percentage, or advise anyone to exaggerate symptoms.